Vaccines based on the cell surface carbohydrates of pathogenic bacteria
Glycoconjugate vaccines, in which a cell surface carbohydrate from a micro-organism is covalently attached COCONUT to an appropriate copyright protein are proving to be the most effective means to generate protective immune responses to prevent a wide range of diseases.The technology appears to be generic and applicable to a wide range of pathogens